Australia TGA ARTG recordtherascreen KRAS RGQ PCR Kit (Cat No. 870081) - Acquired genetic alteration IVDs
Australia TGA ARTG Registered Device · Qiagen Pty Ltd · Qiagen GmbH · Class IIb · Started March 30, 2022
Good Name: Qiagen Pty Ltd - therascreen KRAS RGQ PCR Kit (Cat No. 870081) - Acquired genetic alteration IVDs
- Risk Class
- Class IIb
- Product Type
- IVD
- ARTG Category
- IVD
- Start Date
- March 30, 2022
- Effective Date
- March 30, 2022
- Name
- Qiagen Pty Ltd
- Name
- Qiagen GmbH
- Country
- Germany
- Address
- Qiagen Str 1, Hilden, 40724
IVDs intended for the detection of somatic mutations in oncogenes using nucleic acids extracted from human specimens to guide targeted therapy
Access comprehensive regulatory information for therascreen KRAS RGQ PCR Kit (Cat No. 870081) - Acquired genetic alteration IVDs in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is sponsored by Qiagen Pty Ltd, manufactured by Qiagen GmbH in Germany. The device registration started on March 30, 2022.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.